• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗感染性角膜炎的抗菌药物药物相互作用。

Antimicrobial Drug-Drug Interactions in the Treatment of Infectious Keratitis.

机构信息

Department of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, NY.

出版信息

Cornea. 2023 Dec 1;42(12):1555-1561. doi: 10.1097/ICO.0000000000003304. Epub 2023 Apr 27.

DOI:10.1097/ICO.0000000000003304
PMID:37106486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10611897/
Abstract

PURPOSE

Infectious keratitis is a serious disease requiring immediate, intensive, and broad-spectrum empiric treatment to prevent vision loss. Given the diversity of organisms that can cause serious corneal disease, current guidelines recommend treatment with several antimicrobial agents simultaneously to provide adequate coverage while awaiting results of microbiology cultures. However, it is currently unknown how the use of multiple ophthalmic antimicrobial agents in combination may affect the efficacy of individual drugs.

METHODS

Using a panel of 9 ophthalmic antibiotics, 3 antifungal agents, and 2 antiacanthamoeba therapeutics, fractional inhibitory concentration testing in the standard checkerboard format was used to study 36 antibiotic-antibiotic combinations, 27 antibiotic-antifungal combinations, and 18 antibiotic-antiacanthamoeba combinations against both Staphylococcus aureus and Pseudomonas aeruginosa for synergistic, additive, neutral, or antagonistic drug-drug interactions.

RESULTS

We demonstrate that while most combinations resulted in no change in antimicrobial efficacy of individual components, the combination of erythromycin + polyhexamethylene biguanide was found to be antagonistic toward P. aeruginosa . Conversely, 18 combinations toward S. aureus and 15 combinations toward P. aeruginosa resulted in additive or synergistic activity, including 4 with improved activity toward both species.

CONCLUSIONS

Understanding how drug-drug interactions may affect drug efficacy is critical to selecting the appropriate combination therapy and improving clinical outcomes of this blinding disease.

摘要

目的

感染性角膜炎是一种严重的疾病,需要立即进行强化、广谱的经验性治疗,以防止视力丧失。鉴于可能导致严重角膜疾病的病原体种类繁多,目前的指南建议同时使用几种抗菌药物进行治疗,以在等待微生物培养结果的同时提供充分的覆盖范围。然而,目前尚不清楚联合使用多种眼用抗菌药物会如何影响个别药物的疗效。

方法

使用一组 9 种眼科抗生素、3 种抗真菌药物和 2 种抗棘阿米巴治疗药物,采用标准棋盘格式的部分抑菌浓度测试法,研究了 36 种抗生素-抗生素组合、27 种抗生素-抗真菌组合和 18 种抗生素-抗棘阿米巴组合对金黄色葡萄球菌和铜绿假单胞菌的协同、相加、中性或拮抗药物相互作用。

结果

我们证明,虽然大多数组合对个别成分的抗菌效果没有改变,但发现红霉素+聚六亚甲基双胍组合对铜绿假单胞菌具有拮抗作用。相反,有 18 种针对金黄色葡萄球菌和 15 种针对铜绿假单胞菌的组合具有相加或协同作用,包括 4 种对两种细菌都具有改善作用的组合。

结论

了解药物相互作用如何影响药物疗效对于选择适当的联合治疗方案和改善这种致盲性疾病的临床结局至关重要。

相似文献

1
Antimicrobial Drug-Drug Interactions in the Treatment of Infectious Keratitis.治疗感染性角膜炎的抗菌药物药物相互作用。
Cornea. 2023 Dec 1;42(12):1555-1561. doi: 10.1097/ICO.0000000000003304. Epub 2023 Apr 27.
2
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
3
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2014 Nov 10(11):CD004197. doi: 10.1002/14651858.CD004197.pub4.
4
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
5
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.
6
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验用于指导囊性纤维化患者的抗生素治疗
Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD009528. doi: 10.1002/14651858.CD009528.pub4.
7
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者铜绿假单胞菌慢性感染急性加重期的联合抗菌药物敏感性试验
Cochrane Database Syst Rev. 2015 Nov 2(11):CD006961. doi: 10.1002/14651858.CD006961.pub3.
8
Macrolide antibiotics (including azithromycin) for cystic fibrosis.大环内酯类抗生素(包括阿奇霉素)治疗囊性纤维化。
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5.
9
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验在指导囊性纤维化抗生素治疗中的应用
Cochrane Database Syst Rev. 2015 Mar 5(3):CD009528. doi: 10.1002/14651858.CD009528.pub3.
10
Delayed antibiotic prescriptions for respiratory infections.呼吸道感染的延迟抗生素处方
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5.

引用本文的文献

1
Bacterial and Fungal Keratitis in a Tertiary Care Hospital from Romania.罗马尼亚一家三级护理医院的细菌性和真菌性角膜炎
Microorganisms. 2024 Apr 12;12(4):787. doi: 10.3390/microorganisms12040787.
2
Preparation and Antimicrobial Activity of a Film-Forming Polyhexamethylene Biguanide Teat Disinfectant.成膜型聚六亚甲基双胍奶牛乳房消毒剂的制备与抗菌活性。
Int J Mol Sci. 2023 Dec 13;24(24):17444. doi: 10.3390/ijms242417444.

本文引用的文献

1
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.三联抗生素组合对眼部铜绿假单胞菌临床分离株的抗菌活性。
Transl Vis Sci Technol. 2022 May 2;11(5):26. doi: 10.1167/tvst.11.5.26.
2
Infectious keratitis: A review.感染性角膜炎:综述。
Clin Exp Ophthalmol. 2022 Jul;50(5):543-562. doi: 10.1111/ceo.14113. Epub 2022 Jun 3.
3
Global Current Practice Patterns for the Management of Exogenous Endophthalmitis: A Survey by the American Society of Ophthalmic Trauma.全球治疗眼内异物伤后感染的现状:美国眼外伤学会调查
Curr Eye Res. 2022 May;47(5):802-808. doi: 10.1080/02713683.2021.2016857. Epub 2022 Jan 13.
4
Expert Performance in Visual Differentiation of Bacterial and Fungal Keratitis.视觉区分细菌性和真菌性角膜炎的专家表现。
Ophthalmology. 2022 Feb;129(2):227-230. doi: 10.1016/j.ophtha.2021.09.019. Epub 2021 Oct 6.
5
Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis.多粘菌素单药治疗与联合治疗多重耐药感染的系统评价和荟萃分析
Indian J Crit Care Med. 2021 Feb;25(2):199-206. doi: 10.5005/jp-journals-10071-23720.
6
Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance.感染性角膜炎:流行病学、致病微生物、危险因素及抗菌药物耐药性的最新进展
Eye (Lond). 2021 Apr;35(4):1084-1101. doi: 10.1038/s41433-020-01339-3. Epub 2021 Jan 7.
7
Efficacy of a Novel Ophthalmic Antimicrobial Drug Combination Toward a Large Panel of Staphylococcus aureus Clinical Ocular Isolates From Around the World.一种新型眼科抗菌药物组合对来自世界各地的大量金黄色葡萄球菌临床眼部分离株的疗效。
Cornea. 2020 Oct;39(10):1278-1284. doi: 10.1097/ICO.0000000000002414.
8
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.协同和拮抗药物相互作用在系统性真菌感染的治疗中。
Elife. 2020 May 5;9:e54160. doi: 10.7554/eLife.54160.
9
A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.一种新型广谱抗菌组合药物,用于治疗绿脓杆菌性角膜感染。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00777-19. Print 2019 Oct.
10
International Practice Patterns for the Management of Acute Postsurgical and Postintravitreal Injection Endophthalmitis: European Vitreo-Retinal Society Endophthalmitis Study Report 1.急性手术后及玻璃体内注射后眼内炎管理的国际实践模式:欧洲玻璃体视网膜学会眼内炎研究报告1
Ophthalmol Retina. 2019 Jun;3(6):461-467. doi: 10.1016/j.oret.2019.03.009. Epub 2019 Mar 21.